Rank #1850BRTX

BioRestorative Therapies, Inc.

$0.27

-0.74% (Daily)

Market Cap

$6.25M

Revenue

$383.40K

Rank by MCap

#1850

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Lance Alstodt

Headquarters

Melville, NY

Employees

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral...